Sunday, 7 July 2024
  
Login

Australia's most trusted
source of pharma news

Sunday, 07 July 2024
Listen to this story 
News

Aussie pharma settles class action

Posted 2 July 2024 PM

After almost three years of legal proceedings, Mayne Pharma has agreed to settle a shareholder class action without liability for $38 million.

Phi Finney McDonald filed the suit in August 2021 in the Supreme Court of Victoria alleging Mayne had breached its continuous disclosure obligations and engaged in misleading and deceptive conduct in relation to alleged price-fixing and market share arrangements in the US between 2014 and 2016.

To see the whole article, please login

Popular

Drugs stuck in PBS listing limbo
Omnichannel flops in engaging Drs
Next big meds: the countdown is on
Company on Aussie hiring spree
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (24)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (8)

Other (21)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home